AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Update

AquaBounty Technologies, Inc. (NASDAQ:AQB) saw a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 72,300 shares, a growth of 5.1% from the August 15th total of 68,800 shares. Based on an average daily volume of 23,800 shares, the short-interest ratio is currently 3.0 days. Currently, 2.0% of the shares of the stock are short sold.

AquaBounty Technologies Stock Up 5.1 %

AQB stock opened at $1.23 on Wednesday. AquaBounty Technologies has a 52 week low of $0.81 and a 52 week high of $6.13. The business has a 50-day simple moving average of $1.31 and a 200 day simple moving average of $1.68. The company has a quick ratio of 1.96, a current ratio of 1.96 and a debt-to-equity ratio of 0.05. The company has a market cap of $4.74 million, a PE ratio of -0.14 and a beta of 1.14.

AquaBounty Technologies (NASDAQ:AQB) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($1.56) EPS for the quarter, missing analysts’ consensus estimates of ($0.93) by ($0.63). The business had revenue of $0.18 million for the quarter, compared to analyst estimates of $0.10 million. AquaBounty Technologies had a negative return on equity of 17.81% and a negative net margin of 3,923.57%. Sell-side analysts anticipate that AquaBounty Technologies will post -4.86 EPS for the current fiscal year.

About AquaBounty Technologies

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.